Graney Thomas 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Oct 2, 2018
Insider Transaction Report
Form 4
Graney Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-10-01$193.24/sh−1,076$207,926→ 12,430 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1.